Free Trial
LON:OKYO

OKYO Pharma (OKYO) Share Price, News & Analysis

OKYO Pharma logo

About OKYO Pharma Stock (LON:OKYO)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
1.40
1.40
52-Week Range
N/A
Volume
364,142 shs
Average Volume
431,999 shs
Market Capitalization
£23.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive OKYO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OKYO Pharma and its competitors with MarketBeat's FREE daily newsletter.

OKYO Stock News Headlines

OKYO Pharma Ltd Financials - Morningstar
OKYO Pharma Limited (OKYO) - Yahoo Finance
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
Okyo Pharma announces data on long-term stability of urcosimod
See More Headlines

OKYO Stock Analysis - Frequently Asked Questions

Shares of OKYO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that OKYO Pharma investors own include Avino Silver & Gold Mines (ASM), AutoZone (AZO), Intel (INTC), TJX Companies (TJX), Aurora Cannabis (ACB), Allied Gaming & Entertainment (AGAE) and Academy Sports and Outdoors (ASO).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
LON:OKYO
CIK
N/A
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£6.70 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-397.13%
Return on Assets
-154.72%

Debt

Debt-to-Equity Ratio
1.65
Current Ratio
0.83
Quick Ratio
2.65

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
28.00
Book Value
GBX (1) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,660,000,000
Free Float
N/A
Market Cap
£23.24 million
Optionable
Not Optionable
Beta
-0.06
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (LON:OKYO) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners